The Future of Alliances and Partnerships in the Pre-Filled Syringes Market to 2020

This pre-filled syringes market report examines the key trends, technologies and market influences driving the global pre-filled syringe sector.

£3,950.00

Add to basket Enquire
Product detail
Product type: Market report
Date of publication: 19 Feb 2015
Product format: Hard Copy, Online
Number of pages: 124
Number of tables: 26
Number of figures: 25

This report examines the global market for pre-filled syringes to 2020, including developments relating to the products and technologies used in this field; profiles of manufacturers and key suppliers; and developments in the pharmaceutical and biologics industries that will shape and influence the market.

The Future of Alliances and Partnerships in the Pre-filled Syringes Market to 2020  forecasts that the market for pre-filled syringes will hit $6.6 billion in 2020, representing a CAGR of 10.2% from 2013. In total, nine of the top 10 drugs available in pre-filled syringes are now biologics and the majority of these are used for treating chronic diseases such as diabetes, rheumatoid arthritis and multiple sclerosis.

Description

OUR EXCLUSIVE CONTENT:

  • Analysis of partnerships between big pharma and pre-filled syringe manufacturers
  • Forecasts of the market for pre-filled syringes by region and usage
  • Over 20 in-depth profiles of the leading companies involved in the production of pre-filled syringes.
  • Key trends, technologies and market influences driving the global pre-filled syringe sector

METHODOLOGY

The Future of Alliances and Partnerships in the Pre-filled Syringes Market to 2020  is based on primary and secondary research including interviews with company executives and a wide-ranging review of technical literature, conference papers, medical and scientific journals, company literature and annual reports. Market estimates and forecasts have been modelled based on reported manufacturer revenue using annual reports and other financial documents; from interviews with company executives; company investor presentations; conference materials; and epidemiological, demographic and market data from government statistical sources and international/national healthcare organisations.

WHAT WILL YOU DISCOVER?

  • In-depth analysis of current and future global pre-filled syringe market with forecasts to 2020
  • Extensive analysis of the key market drivers and review of new technologies
  • Details of the industry structure, partnerships, competitive landscape and major players
  • Data broken down by geographical region

WHO SHOULD BUY THIS REPORT?

  • Manufacturers of pre-filled syringes
  • Pharmaceutical companies that use PFS to deliver medicines
  • Suppliers of syringe components; such as glass, plastic & silicone
  • Companies involved in services related to PFS; such as filling
  • Business planners, financial analysts and consultants

WHAT’S INCLUDED IN THE PRICE?

  • An electronic version of the report in PDF format. You may add a hardcopy version  (mailed to you)
  • 5-year market forecasts
  • Analyses of key trends, strategic market  forecasts and original data

Table of Contents

EXECUTIVE SUMMARY

INTRODUCTION AND METHODOLOGY
• Introduction
• Methodology
• Scope and definitions

CURRENT MARKET FOR PREFILLED SYRINGES
• Overview of Market
• Global consumption of pre-filled syringes
• Market by therapy area
o Vaccines
o Antithrombotics
o Autoimmune diseases
o Injection device use by therapy area
 Diabetes
 Anaphylaxis
 Human growth hormone
o Market by geographic region

DRIVERS OF THE MARKET
• Generics: brand differentiation and increasing product lifecycles
• Safety benefits
o Reducing needlestick injuries
o Ease-of-use benefits
o Patient self-injections
• Moving to needle-free injections
• The increasing importance of biologics

LEADING SUPPLIERS OF PREFILLED SYRINGES
Partnerships and the pre-filled syringe supply chain

FORMULATION CONSIDERATIONS AND CHALLENGES
• Drug viscosity
• Lyophilised drugs versus liquid-stable formulations
• Extractables and leachables

PRE-FILLED SYRINGE TECHNOLOGIES
• Glass versus plastic syringes
o Glass: potential problems and technical improvements
 Fragility
 Delamination
 Siliconisation
 Tungsten contamination
o Plastic syringes
 Available products
o Glueless production of plastic syringes
• Pre-filled diluent syringes
• Pen injectors
o Product characteristics
o Product applications
o Product highlights: pre-filled pen injectors
 Becton Dickinson’s Vystra
 Novo Nordisk’s pen injectors
 Sanofi’s SoloSTAR
 Ypsomed’s injectors
o Auto-injectors
 New market opportunities
 Key products
 Aptar Pharma’s Pro-Ject
 BD’s Physioject
 Bespak’s Syrina
 Gerresheimer’s Gx G-Fix adapter
 Owen Mumford’s auto-injectors
 SHL Medical’s Amber and Molly auto-injectors
 Oval Medical Technologies’ plastic auto-injectors
 Needle-free jet injectors
 Crossject’s ZENEO
 Glide Pharmaceutical Technologies’ Glide SDI
 PharmaJet’s PharmaJet Stratis injector
 Valaritas’ Mini-Ject
 Zogenix’ DosePro
 Wearable injectors
 Bespak’s Lapas
 Unilife’s Precision-Therapy and Flex-Therapy products
 Key products in development
 BD Libertas Patch injector
 Enable injections
 Sensile Medical’s SensCore products
 SteadyMed Therapeutics’ PatchPump
 West Pharmaceuticals’ SmartDose

INNOVATIONS IN THE DEVELOPMENT & MANUFACTURE OF PREFILLED SYRINGES
• Safety innovations
o Sharps safety features
• Customisation of pre-filled syringes
o Human factors
• Improved needle technology
o Thin-walled needles
• Manufacturing advances
o Filling technologies and removing the air bubble
o Restricted access barrier systems
• Sterilising syringes
o Electron beam sterilisation tunnels

REGULATORY ENVIRONMENT
• Overview of regulations
o Quality assurance regulations
 FDA 21 CFR Part 4 cGMP Regulations
o FDA regulations
 Pre-filled syringes
 Container closure systems for packaging drugs and biologics
 Injectors as medical devices
 Use of jet injectors with vaccines
 European Union regulations
 Sharps safety legislation
 US Needlestick Safety and Prevention Act
 EU Council Directive 2010/32/EU

MARKET FORECASTS

KEY COMPA NIES
• Ajinomoto Althea
• Antares Pharma
o Key products
o Research and development
o Financial performance
• Baxter International
• Becton, Dickinson and Company
o Pre-fillable syringes
o BD Simplist pre-filled syringes
• Bespak
• Bioject Medical Technologies
• Cambridge Consultants
• CordenPharma
• Covidien
• Crossject
• Gerresheimer
o Glass pre-fillable syringes
o Plastic syringes
o Key partnerships
• Glide Pharmaceutical Technologies
o Product pipeline
• Hospira
o One2One Business
• Medical International Technologies
• MedXL
• National Medical Products
• Nipro
• Owen Mumford
o PharmaJet
• Roselabs
• Schott
o Schott Kaisha
• SHL Group
• Stevanato Group
o Ompi Products
• Terumo Corporation
• Unilife Corporation
o Key products
o Key partnerships
o Flextronics
o Sanofi
o Hikma
o MedImmune
o Novartis
o Biodel
o Undisclosed partner
• Vetter Pharma
• West Pharmaceutical Service
o Packaging Systems
o Delivery Systems Segment
• Ypsomed
o Ypsomed Delivery Systems   

Tables and Figures

  • Global consumption of pre-filled syringes, 2005–14 (units, millions)
  • Pre-filled syringe unit sales growth, 2006–2014 (%)
  • Pre-filled syringe unit sales by geographic region, 2013
  • Components of a typical pre-filled syringe
  • Global consumption of pre-filled syringes, 2005–14 (units, millions)
  • Pre-filled syringe unit sales growth, 2006–2014 (%)
  • Pre-filled syringe unit sales by geographic region, 2013
  • Global pre-filled syringe market value, 2009–14 ($ million)
  • Global pre-filled syringe market growth rates, 2009–14 (%)
  • Pre-filled syringe unit sales by drug therapy area, 2013 (%)
  • Influenza vaccinations distributed in the US 2010–2014 (doses, million)
  • Diabetes prevalence by region, 2014–2035
  • Number of insulin users worldwide, 1990–2014 (millions)
  • Insulin injection device use by region, 2014 (%)
  • Anaphylaxis auto-injector sales, 2004–14 ($ million)
  • Pre-filled syringe consumption by geographic region, 2013
  • Pre-filled syringe revenue by geographic region, 2013
  • Pre-filled syringe market share by company, 2013
  • Components of a typical pre-filled syringe
  • Glass v plastic syringe units sold, 2013 (%)
  • Regional variations in pre-filled vs reusable insulin pen use, 2014 (%)
  • Novo Nordisk: insulin pen market sales by region, 2011–YTD 2014 (%)
  • Estimated Pre-filled syringe consumption, 2013–20 (units, millions)
  • Antares Pharma: pre-filled syringe product and pipeline overview
  • Antares Pharma: injection supplies revenue by customer, 2011–13 ($)
  • Unilife: revenue by geographic region, 2012–14 ($)
  • West Pharmaceutical Services: revenue by division 2011–13 ($)
  • Ypsomed: key partnerships
  • Top 10 injectables sold in pre-filled devices, 2011–2013 ($ millions)
  • Best-selling drugs sold in pre-filled syringe by therapy area, 2013
  • Pre-filled syringe consumption by major geographic region, 2009–13 (units, millions)
  • Pre-filled syringe consumption by major country & region, 2009–13 (units, millions)
  • Pre-filled syringe market by region, 2009–13 ($ millions)
  • Best-selling drugs sold in pre-filled syringe by therapy area, 2013
  • Pre-filled syringe supply and service chain
  • Companies active in the-filled syringe industry
  • Key component suppliers
  • Summary: Type of pre-filled syringe and complementary devices
  • Consumption of plastic vs. glass syringes, 2009–14 (units, millions)
  • Consumption of plastic syringes by region, 2011–14 (units, millions)
  • Summary: Pros and cons of glass & plastic syringes
  • Key pre-filled pen injectors
  • Key auto-injectors
  • Key needle-free jet injectors
  • Key wearable injectors
  • Market growth drivers & expectation to 2020
  • Pre-filled syringe consumption by major geographic region, 2013–20 (units, millions)
  • Pre-filled syringe consumption by major country & region, 2013–20 (units, millions)
  • Pre-filled syringe market value by region, 2013–20 ($ millions)